Clinical Trials Directory

Trials / Completed

CompletedNCT01790256

Comparison of Two Temperatures to Treat Insomnia

A Multi-center Prospective, Blinded, Randomized Crossover Study to Compare the Cerêve Sleep System at Two Different Temperatures in Primary Insomnia Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
144 (actual)
Sponsor
Cereve, Inc. · Industry
Sex
All
Age
22 Years
Healthy volunteers
Not accepted

Summary

Insomnia patients demonstrate subjective and physiological hyperarousal. The Cereve Sleep System has been proposed as a clinical treatment to reverse this hyperarousal in insomnia patients. The current study is a two dose study to determine the optimal temperature for the Cereve Sleep System. Primary outcome measures include EEG sleep measured sleep latency and sleep efficiency.

Conditions

Interventions

TypeNameDescription
DEVICECereve Sleep System at 30 degrees C
DEVICECereve Sleep System at 14-16 degrees C

Timeline

Start date
2013-01-01
Primary completion
2013-08-01
Completion
2013-08-01
First posted
2013-02-13
Last updated
2015-05-22

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01790256. Inclusion in this directory is not an endorsement.